stella
beta
Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke — Stella
Home
/
Patent Foramen Ovale
/
Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke
View on ClinicalTrials.gov
Recruiting
Back to Patent Foramen Ovale trials
Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Canada
IUCPQ, Québec, Quebec